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Background/aim: Cerebral vasospasm is a term that refers to prolonged, slowly progressing but reversible pathological narrowing of
cerebral arteries occurring several days after subarachnoid hemorrhage (SAH), usually accompanied by a decrease in perfusion distal to
the affected artery. Leptin is an endogenous polypeptide hormone that can be carried freely and bound to protein in the blood.
Materials and methods: We investigated the superiority of topical application of leptin that may make a contribution to the development
of new treatment modalities for unconscious patients in brain injury intensive care units and its preventive effect, which is considered to
have multifactorial pathogenesis on cerebral vasospasm occurring after SAH via stereological studies of the basilar artery.
Results: When mean serum leptin levels of the groups were compared, statistically significant differences were observed between the
control and topical leptin-treated groups in favor of the treated groups with respect to serum leptin levels (P < 0.05). In the topical
leptin-applied group, a significant difference in favor of vasodilatation was observed in the measurements of the basilar artery luminal
area (P < 0.05).
Conclusion: In accordance with the results, the topical administration of leptin can be used in the prevention of vasospasm, especially
in unconscious patients with subarachnoid hemorrhage.
Key words: Subarachnoid hemorrhage, cerebral vasospasm, leptin, basilar artery

1. Introduction
Subarachnoid hemorrhage (SAH) is bleeding into
the subarachnoid space, the area between the arachnoid
membrane and the pia mater surrounding the brain,
for a variety of reasons. It is most commonly secondary
to trauma but may also develop spontaneously without
any underlying cause. The actual incidence is not known
exactly because approximately 10% to 15% of patients
with subarachnoid hemorrhage die without any medical
intervention (1). SAH occurs most commonly in people
aged 60 and over. In some studies, it was reported that it is
more frequent in males in autumn and in women in spring
(2,3). Although the incidence of SAH in women is more
frequent, it was reported that the male/female ratio is 4/1
in the first decade of life, equal in the fifth decade, and ten
times higher in women in the sixth decade (4).
Despite the improvements in diagnosis and treatment
strategies, SAH is still an important cause of morbidity and
mortality. In patients with SAH, familial predisposition is
* Correspondence: mehmetemin.onger@gmail.com
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an important risk factor. Studies have revealed that the
incidence of SAH in first- and second-degree relatives of
SAH patients is higher than that in normal populations
(5–7).
Cerebral vasospasm is a pathological chain of events
resulting from slowly developing narrowing in the large
cerebral arteries and late neurological loss due to brain
ischemia or infarction or both (8). Although many
methods of treatment of cerebral vasospasm have been
reported, treatment methods are still controversial.
Leptin is a polypeptide that can be carried in the blood
freely and bound to protein; it involves 167 amino acids
secreted from various tissues and fat cells, weighs 16 kDa,
and constitutes a specific blood level in the plasma (9,10).
Leptin is a hormone that is produced by the ob gene and
released into the plasma (11,12). After finding its way into
the bloodstream, it passes the blood–brain barrier through
its specific receptors, reaches the central nervous system, and
reduces food intake and increases energy expenditure (13).
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Neuroprotection and neurogenesis effects of leptin were
reported in recent studies. Exogenous leptin administration
after ischemic neuronal damage affects the development of
neuronal stem cells and leads to an increase in the number
of neurons, glia cells, and blood vessels in the perilesional
cortex (14,15). Vascular endothelium is considered to be
the target organ for leptin and various scientific studies
have been conducted to determine its functions (16). It
has been demonstrated that intravenous administration
of leptin increases serum nitrite/nitrate concentration and
that exogenous leptin induces nitric oxide (NO) and may
lead to vasodilatation (17). Empirical studies have shown
that synchronous exogenous leptin administration with
N-monomethyl-L-arginine (L-NMMA), a NO synthase
inhibitor, may lead to vasodilatation (18,19). It has been
reported in empirical studies that leptin reaches therapeutic
levels at 30 min in cerebrospinal fluid (CSF) and at 60 min
in serum after topical administration of 10 µL of a 1.2 mg/
mL solution (20). In this study, it was aimed to investigate
the possible topical treatment effects of leptin on cerebral
vasospasm after SAH.
2. Materials and methods
Forty female Sprague-Dawley rats weighing between 280
and 300 g were used in the study. All subjects were kept in
standard laboratory conditions (12/12-h light/dark cycle)
and fed with a standard diet. This study was approved
by the experimental animal studies ethics committee of
Ondokuz Mayıs University (dated 02.06.2012 with number
02-2012/01) and the study was conducted at the Ondokuz
Mayıs University Experimental Animals Research Center.
2.1. Experimental design
• Group 1: Control group (n = 8)
• Group 2: SAH (+), leptin (-), sacrificed on day 3 (n = 8)
• Group 3: SAH (+), leptin (+), sacrificed on day 3 (n = 8)
• Group 4: SAH (+), leptin (-), sacrificed on day 7 (n = 8)
• Group 5: SAH (+), leptin (+), sacrificed on day 7 (n = 8)
2.2. Surgical procedure
General anesthesia was achieved with an intraperitoneal
injection of a ketamine (50 mg/kg) (Ketalar, Eczacıbaşı)
and xylazine (10 mg/kg) (Rompun 2%, Bayer) mixture in
overnight fasted rats. Anesthesia was adjusted to make rats
unresponsive to pain and support spontaneous ventilation.
Additional doses were given if needed. Body temperatures
of rats during the experiment were controlled by a rectal
temperature probe and kept constant at 37 °C. After
maintaining general anesthesia, rats were shaved and a
stereotactic frame was placed with the head flexed at 45°.
The surgical site was cleaned with polyvinylpyrrolidone
iodine. A 2-cm midline occipitocervical flat incision was
made, the occipital muscles and posterior cervical muscles
were dissected, and the atlantooccipital membrane
was exposed (Figure 1). Rats were placed in the supine

Figure 1. View of the atlantooccipital membrane.

position and left inguinal regions were cleaned with
polyvinylpyrrolidone iodine. After skin incision, the
left femoral artery was exposed. After femoral artery
catheterization, 0.1 mL of nonheparinized autologous
arterial blood was taken and rats were placed in the prone
position again. The cisterna magna was entered through
the atlantooccipital membrane with a 25-gauge needle.
After extracting 0.1 mL of CSF, arterial blood in the same
amount was injected slowly for 30 s (Figure 2). Muscle
tissue and skin were sutured and the surgical site was
closed (Figure 3). Rats were placed in a 45° Trendelenburg
position to achieve intracisternal clot formation for 15
min. Rats were kept in cages after fully waking up. Before
the procedure, all subjects were given prophylactic 50
mg/kg i.p. cephalosporin. Polyvinylpyrrolidone iodine
dressing was performed for the surgical wound sites daily
until the rats were sacrificed.
2.3. Leptin administration
The day on which SAH occurred was considered day 0.
The first dose of 10 µL of 1.2 mg/mL leptin in phosphatebuffered saline solution (Sigma-P4417) was administered

Figure 2. Injection of the same amount of arterial blood after
extracting CSF.
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Figure 3. Surgical site was sutured and closed after the surgical
procedure.

to the same eye of the subjects in group 3 three times and
those in group 5 seven times every 24 h.
2.4. Measurement of serum leptin levels
Rat leptin standard solutions were prepared in accordance
with the test protocol. Rat serum samples were diluted 20fold in Eppendorf tubes and made ready for the analysis. The
Rat Leptin ELISA (BioVender, Cat. No:RD2910001200R)
kit procedure was followed for the serum samples obtained
from all subjects (Figure 4).
2.5. Histological and stereological procedures
The chest cavity was opened under general anesthesia using
ketamine and xylazine. For the measurement of serum
leptin levels, intracardiac blood (3 mL) was taken from the
heart and samples were centrifuged, and then serum was
separated and stored at –20 °C. After taking the blood, the
descending aortas of rats were closed with a clamp. An
intracatheter was placed in the left ventricle. Initially, 200

mL of heparin-containing saline solution was given. The
fluid returning to the heart following brain perfusion was
drained by opening the right atrium. Vascular structures
were fixed by giving 10% formalin solution (200 mL). The
brain and brain stem were removed by performing a large
craniectomy. For stereological analysis, prelabeled tubes
containing 10% formalin were monitored via routine light
microscopy. Samples were prepared from the monitored
tissues and embedded in paraffin. After preparing the
paraffin blocks, sections of 15 µm were taken from each
block using microtome in accordance with the principle
of systematic random sampling, one of the basic principles
of stereology. After a routine histological follow-up,
sections were stained with hematoxylin and eosin. Field
measurements were done on the stained sections by using the
Cavalier method (Stereoinvestigator 9.0, MicroBrightField,
Colchester, VT, USA) in the Stereology Workstation. For
these measurements, a point-counting grid was used. The
distance between the points on the grid was determined
as 20 µm × 20 µm according to preliminary examination.
While making calculations on the sections, the pointcounting grid was placed randomly at the relevant sections
on serial cross images and all points intersecting the related
structure were counted. The areas belonging to the basilar
artery lumen and the tunica media layer were restricted.
Two different markers were used for two different fields,
and the field measurements were performed (Figure 5).
Point density of the point-counting grid was determined by
considering the number of serial light microscopic images
specified by an appropriate coefficient of error (21,22).
Counting was performed in all groups according to the point
density determined by the coefficient of error calculated in
the pilot study. Obtained results were put in the relevant
place in the following formula and field measurements of
above-mentioned parameters were calculated (23):

Figure 4. Performing ELISA procedure for the serum samples.
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3. Results
Serum leptin levels (Table 1; Figure 6), basilar artery lumen
area (Table 2; Figure 7A) and t. media thickness of the
groups (Table 3; Figure 7B) are shown. Histopathological
appearances of basilar arteries are shown in Figure 8.
In accordance with the data obtained from this study, a
statistically significant difference was observed between
group 1 and topical leptin-treated groups 2 and 5 in favor
of the treated groups (P < 0.05). These results show that
topical administration of leptin finds its way into the
systemic circulation.
When group 5, which was treated with topical leptin
for 7 days after SAH, was compared with group 1 and
group 4, a statistically significant difference was observed
in favor of vasodilatation in the basilar artery lumen
area measurements (P < 0.05), whereas no statistically
significant difference was observed between media layers
(P > 0.05). The highest media/lumen ratio was in group 4
(0.46), whereas the lowest ratio was in group 5 (0.18).
Table 1. Serum leptin levels of the groups.
Serum leptin levels (pg/mL)

Figure 5. Using the Cavalier method in the Stereology
Workstation. (A) The light microscopic appearance of the basilar
artery of the rat. Estimating of the artery lumen (green) and the
tunica media layer (pink) is shown (B and C).

Groups

Mean ± SD

1

2192.90 ± 260.28

2

2115.53 ± 223.70

3

3682.12 ± 387.49

4

1994.71 ± 324.00

5

4753.67 ± 592.54

SERUM LEPTIN LEVELS (pg/mL)

Area = a/p (µm × µm) × (SP) µm2
a/p: the space between two points
SP: total number of points intersecting the structure
2.6. Statistical analysis
Statistical analysis was performed using SPSS 20.0 for
Windows. A normality test was done prior to analysis.
The normality test revealed that data were normally
distributed. Data were analyzed using one-way analysis
of variance (ANOVA). The Tukey test was used for
multiple comparisons. For comparisons of groups, a 0.05
significance level was used.

Figure 6. Serum leptin levels of the groups are seen.
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Table 2. The area of the basilar artery lumen.

Table 3. Tunica media thickness of the basilar artery.

Basilar artery luman area (µm2)

Thickness of tunica media (µm)

Groups

Mean ± SD

Groups

Mean ± SD

1

1,192,640 ± 162,068

1

278,070 ± 46,222

2

935,600 ± 159,247

2

277,150 ± 52,939

3

1,060,866 ± 115,310

3

226,950 ± 39,604

4

622,666 ± 106,287

4

217,600 ± 40,638

5

974,333 ± 145,644

5

196,800 ± 25,243

4. Discussion
The pathogenesis of cerebral vasospasm cannot be
explained clearly but it is considered to be multifactorial.
Cerebral vasospasm is one of the most important causes
of morbidity and mortality in today’s brain surgery. This
can be attributed to ineffective treatments and their
undesirable detrimental effects (24).
The main problem in patients with SAH is symptomatic
brain ischemia developing in the subacute period (between
3 and 14 days) as a result of persistent vasospasm in the
intracranial artery. Despite many experimental and clinical
studies, effective treatment and prevention method could
not be found (25). The presence of cerebral vasospasm in
the first 2 weeks after SAH increases mortality up to 1.5–3
times (26).
Unlike the peripheral system arteries, adventitia layers
are not well developed in intracranial arteries in the
subarachnoid space. Erythrocyte cell infiltration is seen in

pores of these arteries, which are fed through CSF from
adventitia. Thus, a situation similar to SAH and vasospasm
in humans can be provided. In addition, since collateral
circulation is well developed in animals, neurological
deficit resulting from vasospasm occurs rarely. Another
advantage of using the basilar artery is that the posterior
circulation of animals is well developed. In our study, a
SAH model, the most preferred and widely used method,
was used via autologous blood injection (27).
Angiography, transcranial Doppler, and histological
measurements are commonly used methods in the
evaluation of experimental vasospasm. On the other hand,
other methods such as measurements of regional cerebral
blood flow and transcranial magnetic stimulations have
also been reported (28–32). Since they are reliable and
give quantitative results, we carried out evaluations using
stereological measurements in our study.

Figure 7. Lumen area (A) and tunica media thickness (B) of basilar artery of the groups.
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Figure 8. Histopathological view of the basilar arteries of the groups is seen. *; lumen of the artery. Hematoxylin and
eosin staining.

Leptin is a hormone that is produced by the ob gene
and released into the plasma (12,33). After finding its way
into the bloodstream, it passes the blood–brain barrier
and reaches the central nervous system through its specific
receptors and reduces food intake and increases energy
expenditure (34).
Nakagawa et al. and Matsuda et al. showed that
synchronously administered exogenous leptin and

N-monomethyl-L-arginine (L-NMMA), a NO synthase
inhibitor, can lead to vasodilatation (16,17).
In his study, Raymond showed peak CSF and
serum leptin levels at 30 and 60 min respectively after
administering 10 µL of a 1.2 mg/mL solution of rat leptin
eye drops (19).
In our study, we investigated the superiority of a
topical application (eye drops) of leptin that may make
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a contribution to the development of new treatment
modalities for unconscious patients in brain injury
intensive care units and its preventive effect, which is
considered to have multifactorial pathogenesis on cerebral
vasospasm occurring after SAH.
When tunica media area/luminal areas ratio were
evaluated, having the highest and lowest rates in group
4 (0.46) and group 5 (0.18) respectively suggested that
morphological changes occurred on the 7th day. Having
the highest and lowest rates in group 4 (0.46) and group
5 (0.18) respectively also suggested that possible luminal
narrowing and expansion are controlled by thickness in
the tunica media as well as other intracellular means.
Watson et al. stated that leptin exhibits antioxidant
activity indirectly by increasing the levels of catalase,
glutathione peroxidase, and glutathione reductase, which
are antioxidant enzymes (33). We are of the opinion that
the intracellular change caused by leptin is responsible for
this result. This approach is consistent with those reported
by Lembo et al. (34).

Avraham et al. reported that leptin has significant
neuroprotective, neurogenetic, and angiogenetic effects
after ischemia (13). The results obtained from that study
may have resulted from the possible angiogenetic effect of
leptin. We are of the opinion that the current angiogenetic
effect of leptin occurs as an increase in lumen diameter
and subsequently vascular endothelial growth factor.
As well as its vasodilator effect, antioxidant,
angiogenetic, and neuroprotective effects of leptin increase
the success rate of the treatment. The topical applicability
of leptin in unconscious patients with SAH for the
prevention of cerebral vasospasm should be considered
and much research on this issue must be planned.
Therapeutic doses recommended in the literature
were administered in this study. It was shown in the
measurements of serum leptin levels that leptin finds its
way into the systemic circulation effectively after topically
administration (eye drops). It was also shown that topical
administration of leptin leads to vasodilatation in basilar
artery vasospasm resulting from experimental SAH.
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